Esmaeil Behmard
Impact in
-
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- vaccines and immunoinformatics approaches 6
- Oncology 7
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Ebrahim Barzegari (6 shared papers)Ali Najafi (5 shared papers)Parviz Abdolmaleki (6 shared papers)Sohrab Najafipour (8 shared papers)Abdolmajid Ghasemian (8 shared papers)Ali Ahmadi (3 shared papers)Samad Jahandideh (1 shared paper)Majid Taghdir (2 shared papers)
In The Last Decade
Esmaeil Behmard
29 papers receiving 269 citations
Peers
Comparison fields: 5 of 73
- Infectious Diseases 53
- Microbiology 17
- Hepatology 17
- Molecular Biology 157
- Molecular Medicine 9
Countries citing papers authored by Esmaeil Behmard
This map shows the geographic impact of Esmaeil Behmard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esmaeil Behmard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esmaeil Behmard more than expected).
Fields of papers citing papers by Esmaeil Behmard
This network shows the impact of papers produced by Esmaeil Behmard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esmaeil Behmard. The network helps show where Esmaeil Behmard may publish in the future.
Co-authors
The 25 scholars most cited alongside Esmaeil Behmard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 54 | |
| 2 | 2022 | 37 | |
| 3 | 2011 | 20 | |
| 4 | 2022 | 14 | |
| 5 | 2017 | 14 | |
| 6 | 2022 | 14 | |
| 7 | 2024 | 13 | |
| 8 | 2024 | 12 | |
| 9 | 2018 | 12 | |
| 10 | 2023 | 10 | |
| 11 | 2022 | 9 | |
| 12 | 2023 | 7 | |
| 13 | 2022 | 6 | |
| 14 | 2024 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2023 | 5 | |
| 17 | 2023 | 5 | |
| 18 | 2012 | 4 | |
| 19 | 2018 | 4 | |
| 20 | 2024 | 4 |
About Esmaeil Behmard
Esmaeil Behmard is a scholar working on Molecular Biology, Oncology, Infectious Diseases, Immunology and Molecular Medicine, having authored 30 papers that have together received 271 indexed citations. Recurring topics across this work include vaccines and immunoinformatics approaches (6 papers), Drug Transport and Resistance Mechanisms (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Antibiotic Resistance in Bacteria (4 papers), Antimicrobial Peptides and Activities (3 papers), HIV/AIDS drug development and treatment (3 papers), Computational Drug Discovery Methods (3 papers) and Hepatitis C virus research (3 papers). The work is most often cited by research in Infectious Diseases (53 citations), Microbiology (17 citations), Hepatology (17 citations), Molecular Biology (157 citations) and Molecular Medicine (9 citations). Esmaeil Behmard has collaborated with scholars based in Iran, Iraq and Sudan. Frequent co-authors include Ebrahim Barzegari, Ali Najafi, Parviz Abdolmaleki, Sohrab Najafipour, Abdolmajid Ghasemian, Ali Ahmadi, Samad Jahandideh, Majid Taghdir, Seyed Amin Kouhpayeh and Saade Abdalkareem Jasim. Their work appears in journals such as Journal of Biomolecular Structure and Dynamics, Scientific Reports, International Immunopharmacology, Journal of Molecular Graphics and Modelling and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.